-
Alzheimer’s disease: cheap nutrients outperform latest drug
05 October 2022
Acclaimed nutritionist Patrick Holford speaks to ANH Founder Rob Verkerk PhD about the Food for the Brain Foundation’s launch of the ‘Alzheimer’s is Preventable’ campaign
-
Remdesivir – out of the ashes but no miracle cure
28 May 2020
How did Gilead’s Remdesivir go from failure to a ‘miracle’ drug for Covid-19?
-
ANH News Beat (week 39/2024)
25 September 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week US court rules in landmark fluoride case; Are weight loss drugs really a panacea for obesity epidemic?; GMO news; Will EU take action on toxic chemicals?; ANH-USA updates plus the latest covid related news and much more...
-
Natural exploitation by Big Pharma
18 October 2017
As patents on existing drugs run out, Big Pharma is turning its attention (back) to the natural world
-
Vit B3 in the crosshairs—should you worry?
21 March 2024
ANH-USA's medical director, Ron Hoffman MD, examines a new study bashing vitamin B3 (niacin)
-
The new dawn of mRNA technology
11 May 2023
Republishing article by Rob Verkerk PhD for Dr Ron Hoffman's Intelligent Medicine: Cancer patients look to be next in line for experimental mRNA shots
News / ANH Covid Zone / Health / Campaigns
-
Covid News Unwrapped (week 35/2022)
31 August 2022
Our curated roundup of global covid news and information continues as we document the effects of the coronavirus crisis and its ongoing legacy
News / ANH Covid Zone / Health / Campaigns
-
Vanden Bossche selection pressure in plain English
01 December 2021
Rob Verkerk PhD and David Lorimer attempt to tame the increasingly convincing theories of a Belgian vaccinologist
News / ANH Covid Zone / Health / Campaigns
-
Vaccine transparency – more needed now than ever
03 June 2020
Why we can no longer accept being told what’s in our food but not what’s in our vaccines
-
Is news on the statin-beating, cholesterol-lowering jab too good to be true?
05 February 2020
Award-winning journalist Jerome Burne and ANH’s Rob Verkerk explore behind the headlines